Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci

The Consortium of Investigators of Modifiers of BRCA1/2

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Understanding the regulatory landscape of the human genome is a central question in complex trait genetics. Most singlenucleotide polymorphisms (SNPs) associated with cancer risk lie in non-protein-coding regions, implicating regulatory DNA elements as functional targets of susceptibility variants. Here, we describe genome-wide annotation of regions of open chromatin and histone modification in fallopian tube and ovarian surface epithelial cells (FTSECs, OSECs), the debated cellular origins of high-grade serous ovarian cancers (HGSOCs) and in endometriosis epithelial cells (EECs), the likely precursor of clear cell ovarian carcinomas (CCOCs). The regulatory architecture of these cell types was compared with normal human mammary epithelial cells and LNCaP prostate cancer cells. We observed similar positional patterns of global enhancer signatures across the three different ovarian cancer precursor cell types, and evidence of tissue-specific regulatory signatures compared to nongynecological cell types. We found significant enrichment for risk-associated SNPs intersecting regulatory biofeatures at 17 known HGSOC susceptibility loci in FTSECs (P = 3.8 × 10-30), OSECs (P = 2.4 × 10-23) and HMECs (P = 6.7 × 10-15) but not for EECs (P = 0.45) or LNCaP cells (P = 0.88). Hierarchical clustering of risk SNPs conditioned on the six different cell types indicates FTSECs and OSECs are highly related (96% of samples using multi-scale bootstrapping) suggesting both cell types may be precursors of HGSOC. These data represent the first description of regulatory catalogues of normal precursor cells for different ovarian cancer subtypes, and provide unique insights into the tissue specific regulatory variation with respect to the likely functional targets of germline genetic susceptibility variants for ovarian cancer.

Original languageEnglish (US)
Article numberddv101
Pages (from-to)3595-3607
Number of pages13
JournalHuman Molecular Genetics
Volume24
Issue number13
DOIs
StatePublished - Jul 1 2015

Fingerprint

Ovarian Neoplasms
Epithelial Cells
Endometriosis
Histone Code
Fallopian Tubes
Nucleic Acid Regulatory Sequences
Human Genome
Genetic Predisposition to Disease
Chromatin
Cluster Analysis
Prostatic Neoplasms
Breast
Genome
Carcinoma
DNA

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. / The Consortium of Investigators of Modifiers of BRCA1/2.

In: Human Molecular Genetics, Vol. 24, No. 13, ddv101, 01.07.2015, p. 3595-3607.

Research output: Contribution to journalArticle

The Consortium of Investigators of Modifiers of BRCA1/2. / Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. In: Human Molecular Genetics. 2015 ; Vol. 24, No. 13. pp. 3595-3607.
@article{7c90319cbd04455ab216126e40a3866b,
title = "Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci",
abstract = "Understanding the regulatory landscape of the human genome is a central question in complex trait genetics. Most singlenucleotide polymorphisms (SNPs) associated with cancer risk lie in non-protein-coding regions, implicating regulatory DNA elements as functional targets of susceptibility variants. Here, we describe genome-wide annotation of regions of open chromatin and histone modification in fallopian tube and ovarian surface epithelial cells (FTSECs, OSECs), the debated cellular origins of high-grade serous ovarian cancers (HGSOCs) and in endometriosis epithelial cells (EECs), the likely precursor of clear cell ovarian carcinomas (CCOCs). The regulatory architecture of these cell types was compared with normal human mammary epithelial cells and LNCaP prostate cancer cells. We observed similar positional patterns of global enhancer signatures across the three different ovarian cancer precursor cell types, and evidence of tissue-specific regulatory signatures compared to nongynecological cell types. We found significant enrichment for risk-associated SNPs intersecting regulatory biofeatures at 17 known HGSOC susceptibility loci in FTSECs (P = 3.8 × 10-30), OSECs (P = 2.4 × 10-23) and HMECs (P = 6.7 × 10-15) but not for EECs (P = 0.45) or LNCaP cells (P = 0.88). Hierarchical clustering of risk SNPs conditioned on the six different cell types indicates FTSECs and OSECs are highly related (96{\%} of samples using multi-scale bootstrapping) suggesting both cell types may be precursors of HGSOC. These data represent the first description of regulatory catalogues of normal precursor cells for different ovarian cancer subtypes, and provide unique insights into the tissue specific regulatory variation with respect to the likely functional targets of germline genetic susceptibility variants for ovarian cancer.",
author = "{The Consortium of Investigators of Modifiers of BRCA1/2} and Coetzee, {Simon G.} and Shen, {Howard C.} and Hazelett, {Dennis J.} and Kate Lawrenson and Karoline Kuchenbaecker and Jonathan Tyrer and Rhie, {Suhn K.} and Keren Levanon and Alison Karst and Ronny Drapkin and Ramus, {Susan J.} and Couch, {Fergus J} and Kenneth Offit and Georgia Chenevix-Trench and Monteiro, {Alvaro N A} and Antonis Antoniou and Matthew Freedman and Coetzee, {Gerhard A.} and Pharoah, {Paul D P} and Houtan Noushmehr and Gayther, {Simon A.} and Hoda Anton-Culver and Natalia Antonenkova and Helen Baker and Bandera, {Elisa V.} and Yukie Bean and Beckmann, {Matthias W.} and Andrew Berchuck and Maria Bisogna and Line Bjorge and Natalia Bogdanova and Brinton, {Louise A.} and Angela Brooks-Wilson and Fiona Bruinsma and Ralf Butzow and Campbell, {Ian G.} and Karen Carty and Jenny Chang-Claude and Ann Chen and Zhihua Chen and Cook, {Linda S.} and Cramer, {Daniel W.} and Cunningham, {Julie M} and Cezary Cybulski and Agnieszka Dansonka-Mieszkowska and Joe Dennis and Ed Dicks and Doherty, {Jennifer A.} and Thilo D{\"o}rk and Goode, {Ellen L}",
year = "2015",
month = "7",
day = "1",
doi = "10.1093/hmg/ddv101",
language = "English (US)",
volume = "24",
pages = "3595--3607",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "13",

}

TY - JOUR

T1 - Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci

AU - The Consortium of Investigators of Modifiers of BRCA1/2

AU - Coetzee, Simon G.

AU - Shen, Howard C.

AU - Hazelett, Dennis J.

AU - Lawrenson, Kate

AU - Kuchenbaecker, Karoline

AU - Tyrer, Jonathan

AU - Rhie, Suhn K.

AU - Levanon, Keren

AU - Karst, Alison

AU - Drapkin, Ronny

AU - Ramus, Susan J.

AU - Couch, Fergus J

AU - Offit, Kenneth

AU - Chenevix-Trench, Georgia

AU - Monteiro, Alvaro N A

AU - Antoniou, Antonis

AU - Freedman, Matthew

AU - Coetzee, Gerhard A.

AU - Pharoah, Paul D P

AU - Noushmehr, Houtan

AU - Gayther, Simon A.

AU - Anton-Culver, Hoda

AU - Antonenkova, Natalia

AU - Baker, Helen

AU - Bandera, Elisa V.

AU - Bean, Yukie

AU - Beckmann, Matthias W.

AU - Berchuck, Andrew

AU - Bisogna, Maria

AU - Bjorge, Line

AU - Bogdanova, Natalia

AU - Brinton, Louise A.

AU - Brooks-Wilson, Angela

AU - Bruinsma, Fiona

AU - Butzow, Ralf

AU - Campbell, Ian G.

AU - Carty, Karen

AU - Chang-Claude, Jenny

AU - Chen, Ann

AU - Chen, Zhihua

AU - Cook, Linda S.

AU - Cramer, Daniel W.

AU - Cunningham, Julie M

AU - Cybulski, Cezary

AU - Dansonka-Mieszkowska, Agnieszka

AU - Dennis, Joe

AU - Dicks, Ed

AU - Doherty, Jennifer A.

AU - Dörk, Thilo

AU - Goode, Ellen L

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Understanding the regulatory landscape of the human genome is a central question in complex trait genetics. Most singlenucleotide polymorphisms (SNPs) associated with cancer risk lie in non-protein-coding regions, implicating regulatory DNA elements as functional targets of susceptibility variants. Here, we describe genome-wide annotation of regions of open chromatin and histone modification in fallopian tube and ovarian surface epithelial cells (FTSECs, OSECs), the debated cellular origins of high-grade serous ovarian cancers (HGSOCs) and in endometriosis epithelial cells (EECs), the likely precursor of clear cell ovarian carcinomas (CCOCs). The regulatory architecture of these cell types was compared with normal human mammary epithelial cells and LNCaP prostate cancer cells. We observed similar positional patterns of global enhancer signatures across the three different ovarian cancer precursor cell types, and evidence of tissue-specific regulatory signatures compared to nongynecological cell types. We found significant enrichment for risk-associated SNPs intersecting regulatory biofeatures at 17 known HGSOC susceptibility loci in FTSECs (P = 3.8 × 10-30), OSECs (P = 2.4 × 10-23) and HMECs (P = 6.7 × 10-15) but not for EECs (P = 0.45) or LNCaP cells (P = 0.88). Hierarchical clustering of risk SNPs conditioned on the six different cell types indicates FTSECs and OSECs are highly related (96% of samples using multi-scale bootstrapping) suggesting both cell types may be precursors of HGSOC. These data represent the first description of regulatory catalogues of normal precursor cells for different ovarian cancer subtypes, and provide unique insights into the tissue specific regulatory variation with respect to the likely functional targets of germline genetic susceptibility variants for ovarian cancer.

AB - Understanding the regulatory landscape of the human genome is a central question in complex trait genetics. Most singlenucleotide polymorphisms (SNPs) associated with cancer risk lie in non-protein-coding regions, implicating regulatory DNA elements as functional targets of susceptibility variants. Here, we describe genome-wide annotation of regions of open chromatin and histone modification in fallopian tube and ovarian surface epithelial cells (FTSECs, OSECs), the debated cellular origins of high-grade serous ovarian cancers (HGSOCs) and in endometriosis epithelial cells (EECs), the likely precursor of clear cell ovarian carcinomas (CCOCs). The regulatory architecture of these cell types was compared with normal human mammary epithelial cells and LNCaP prostate cancer cells. We observed similar positional patterns of global enhancer signatures across the three different ovarian cancer precursor cell types, and evidence of tissue-specific regulatory signatures compared to nongynecological cell types. We found significant enrichment for risk-associated SNPs intersecting regulatory biofeatures at 17 known HGSOC susceptibility loci in FTSECs (P = 3.8 × 10-30), OSECs (P = 2.4 × 10-23) and HMECs (P = 6.7 × 10-15) but not for EECs (P = 0.45) or LNCaP cells (P = 0.88). Hierarchical clustering of risk SNPs conditioned on the six different cell types indicates FTSECs and OSECs are highly related (96% of samples using multi-scale bootstrapping) suggesting both cell types may be precursors of HGSOC. These data represent the first description of regulatory catalogues of normal precursor cells for different ovarian cancer subtypes, and provide unique insights into the tissue specific regulatory variation with respect to the likely functional targets of germline genetic susceptibility variants for ovarian cancer.

UR - http://www.scopus.com/inward/record.url?scp=84936771937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936771937&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddv101

DO - 10.1093/hmg/ddv101

M3 - Article

C2 - 25804953

AN - SCOPUS:84936771937

VL - 24

SP - 3595

EP - 3607

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 13

M1 - ddv101

ER -